Novo Nordisk Selects AWS as Strategic Partner to Accelerate Drug Discovery with AI
emmanuelvivier · x · 2026-08-17
- Novo Nordisk selected AWS as a strategic partner to accelerate drug discovery processes.
- The collaboration will leverage AWS's cloud services and AI capabilities to enhance R&D efficiency.
More from Companies & People
- DeepSeek launches coding-focused model to rival Anthropic, OpenAI — pstAsiatech · 2026-08-17
- New r/posttrain community focuses on AI post-training and fine-tuning — OwnOil1149 · 2026-08-17
- The Tech Press Has Become Too Comfortable With the Companies It Covers — DavidLinthicum · 2026-08-17
- Max Planck School of Biomedical AI PhD program opens applications in Sept 2026 — kmborgwardt · 2026-08-17
- FAQ for Google DeepMind India AI Residency Program Shared by User — jainprateek_ · 2026-08-17
- Tech Media Independence Questioned: Advertisers May Influence Coverage — DavidLinthicum · 2026-08-17